Evidence map›Paper›PMID 37456196›Full record

ArticleIndian journal of nuclear medicine : IJNM : the official journal of the Society of Nuclear Medicine, India

Angiogenesis Imaging of Adrenocortical Carcinoma with Ga-68-NODAGA-RGD Positron Emission Tomography: Opening New Horizons in Multimodality Imaging from Theranostic Perspective.

Priyanka Verma, Ashok Chandak, Suyog Sharad Shetye, Aamir K Nazar, Swati Dinesh Bagul, Gaurav Malhotra

Open access · hybridAbstract read
In one paragraph

Article in Indian journal of nuclear medicine : IJNM : the official journal of the Society of Nuclear Medicine, India. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 83% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Priyanka VermaRadiation Medicine Centre, Bhabha Atomic Research Centre, Mumbai, Maharashtra, India.
Ashok ChandakRadiation Medicine Centre, Bhabha Atomic Research Centre, Mumbai, Maharashtra, India.
Suyog Sharad ShetyeDepartment of Surgery, Seth G S Medical College and King Edward Memorial Hospital, Mumbai, Maharashtra, India.
Aamir K NazarRadiation Medicine Centre, Bhabha Atomic Research Centre, Mumbai, Maharashtra, India.
Swati Dinesh BagulRadiation Medicine Centre, Bhabha Atomic Research Centre, Mumbai, Maharashtra, India.
Gaurav MalhotraRadiation Medicine Centre, Bhabha Atomic Research Centre, Mumbai, Maharashtra, India.
Bhabha Atomic Research Centre · INKing Edward Memorial Hospital and Seth G.S. Medical College · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A 53-year-old female, with a known case of adrenocortical carcinoma (ACC), underwent F-18 fluorodeoxyglucose (FDG) positron emission tomography/computed tomography (PET/CT) for initial staging, which revealed FDG avid large left suprarenal mass contiguous with hypermetabolic tumor thrombus in the inferior vena cava (IVC) through the left renal vein. Thereafter, she underwent angiogenesis imaging using Ga-68-NODAGA-RGD PET/CT, which showed similar avid tracer uptake in both primary and IVC thrombus. Demonstration of RGD avidity in ACC in this case opens a new horizon for targeted radionuclide therapy (e.g., Lu-177 RGD) in selected patients, who may have limited therapeutic options.

Indexed as

Adrenocortical carcinomaF-18 fluorodeoxyglucose positron emission tomography/computed tomographyGa-68-NODAGA-RGD positron emission tomography/computed tomographyLu-177 RGD

Identifiers

PMID37456196
PMCPMC10348488
OpenAlexW4380189374

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.